DBV TECHNOLOGIES

NJ

Pharmaceutical Company

Active 2024–2026.

Filings
11
Filed By
1
Reported In-House
—
Reported By Firms
$370,000

Filings

YearFirmPeriodAmountDoc
2025 WINNING STRATEGIES WASHINGTON 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$40,000
2025 WINNING STRATEGIES WASHINGTON 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$40,000
2025 WINNING STRATEGIES WASHINGTON 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$40,000
2025 WINNING STRATEGIES WASHINGTON 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$40,000
Filed By
FirmFilingsAmount
WINNING STRATEGIES WASHINGTON 11 $370,000
Issue Areas
IssueActivities
Health Issues 10
Pharmacy 1